HGHSX | JFNIX | HGHSX / JFNIX | |
Total Expense Ratio | 1.29 | 0.77 | 168% |
Annual Report Gross Expense Ratio | 1.29 | 0.77 | 168% |
Fund Existence | 18 years | 16 years | - |
Gain YTD | -3.535 | -4.719 | 75% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 2500 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 856M | 4.71B | 18% |
Annual Yield % from dividends | 0.00 | 0.39 | - |
Returns for 1 year | -8.68 | -8.00 | 109% |
Returns for 3 years | -10.10 | -2.20 | 459% |
Returns for 5 years | -6.62 | 12.91 | -51% |
Returns for 10 years | -10.67 | 9.91 | -108% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 20.97 | 0.76 | +3.76% |
ProShares UltraShort Nasdaq Biotech | |||
CMBS | 47.81 | 0.19 | +0.40% |
iShares CMBS ETF | |||
FALN | 25.89 | N/A | N/A |
iShares Fallen Angels USD Bond ETF | |||
JPMB | 37.43 | -0.01 | -0.02% |
JPMorgan USD Emerging Mkts Svr Bd ETF | |||
HEEM | 26.41 | -0.45 | -1.67% |
iShares Currency Hedged MSCI Em Mkts ETF |